Jun 11, 2026 03:03PM
May 7, 2026 07:30AM
Feb 24, 2026 07:30AM
Feb 23, 2026 06:58AM
Feb 17, 2026 08:05AM
Jan 12, 2026 08:07AM
Jan 12, 2026 08:05AM Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
Dec 16, 2025 06:30AM
Dec 16, 2025 06:30AM
Nov 25, 2025 06:53AM
Nov 24, 2025 08:06AM
Nov 24, 2025 08:05AM
Nov 4, 2025 07:30AM
Oct 23, 2025 08:05AM Harmony Biosciences raises 2025 revenue guidance on strong WAKIX sales
Oct 23, 2025 08:05AM
Sep 24, 2025 08:00AM
Sep 24, 2025 08:00AM
Aug 5, 2025 07:30AM
Aug 5, 2025 07:30AM
Jun 11, 2025 08:06AM
Jun 11, 2025 08:05AM Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025
Jun 5, 2025 08:06AM
Jun 5, 2025 08:05AM
May 6, 2025 07:30AM
Apr 8, 2025 08:05AM
Apr 8, 2025 08:05AM
Mar 24, 2025 08:05AM
Mar 24, 2025 08:05AM Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands
Feb 27, 2025 06:59AM
Feb 26, 2025 09:37AM
Feb 25, 2025 07:30AM
Feb 20, 2025 06:52AM
Feb 20, 2025 06:11AM
Feb 19, 2025 08:05AM
Feb 19, 2025 08:05AM Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia
Jan 29, 2025 09:12AM
Jan 17, 2025 06:38AM
Jan 13, 2025 08:17AM
Jan 13, 2025 08:05AM
Oct 29, 2024 07:30AM
Oct 1, 2024 08:47AM
Oct 1, 2024 08:45AM HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY
Aug 6, 2024 07:30AM
Aug 6, 2024 07:30AM
Aug 1, 2024 08:00AM
Jun 25, 2024 11:33AM
Jun 25, 2024 08:09AM
Jun 25, 2024 08:05AM
Jun 24, 2024 01:41PM Citi Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
Jun 24, 2024 11:43AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All